Symptoms of Carbidopa/Levodopa Overdose
Carbidopa/levodopa overdose primarily causes involuntary movements (dyskinesias including choreiform movements), psychiatric disturbances (hallucinations, confusion, agitation, delirium), cardiovascular instability (hypotension, tachycardia), and gastrointestinal symptoms (nausea, vomiting). 1
Primary Manifestations
Movement Disorders
The hallmark of carbidopa/levodopa excess is dyskinesias—involuntary movements that can be:
- Choreiform movements (dance-like, jerky movements)
- Dystonic movements (sustained muscle contractions)
- Other involuntary movements 1
In severe overdose cases, these choreiform movements can persist despite sedation and may require prolonged paralysis (up to 60 hours documented) with mechanical ventilation 2. The movements can be so severe they lead to rhabdomyolysis with elevated creatine phosphokinase and myoglobinuria 2.
Psychiatric and Neurological Symptoms
Overdose produces a characteristic constellation of mental status changes:
- Psychomotor agitation and delirium
- Visual hallucinations
- Confusion and disorientation
- Logorrhea (excessive talking)
- Joviality or euphoria
- Paranoid ideation and delusions 1, 3
These psychiatric symptoms can have a biphasic pattern with controlled-release formulations, reappearing 48 hours after initial ingestion 3.
Cardiovascular Effects
The cardiovascular response is often biphasic:
- Initial hypertension followed rapidly by hypotension 4
- Sinus tachycardia (often persistent)
- Orthostatic hypotension (can be prolonged and symptomatic)
- Cardiac irregularities and palpitations 1, 3, 4
Autonomic Symptoms
Gastrointestinal Symptoms
Critical Clinical Pitfall: Controlled-Release Formulations
With controlled-release carbidopa/levodopa formulations, patients require extended observation (at least 66 hours) due to biphasic catecholamine peaks. 3 The case literature demonstrates:
- First dopamine peak at ~14 hours post-ingestion
- Second peak at ~38 hours with recurrence of clinical toxicity
- Clinical signs may resolve then reappear 48 hours later 3
This biphasic pattern means patients cannot be safely discharged after initial symptom resolution with extended-release preparations.
Additional Concerning Features
Impulse Control Disorders
Even at therapeutic doses, carbidopa/levodopa can cause:
- Pathological gambling
- Hypersexuality and increased libido
- Compulsive spending
- Binge eating
- Other uncontrollable urges 1
Laboratory Abnormalities
- Dark-colored urine, saliva, or sweat (red, brown, or black)
- Elevated creatine phosphokinase (with severe dyskinesias)
- Myoglobinuria
- Abnormal liver function tests 1, 2
Management Considerations
Treatment is symptomatic and supportive 3. The dyskinesias may not respond to typical sedatives (naloxone, morphine, diazepam ineffective in documented cases) 2. Severe cases may require:
- Mechanical ventilation
- Neuromuscular blockade for refractory dyskinesias
- Monitoring for rhabdomyolysis complications 2
Patients may develop amnesia for the overdose event 3, which is an important consideration for psychiatric evaluation and prevention of repeat episodes.